About our research

Our team is utilising the latest genetic and nanoparticle technology to develop new therapies to treat incurable inherited retinal diseases (IRDs) and also longer lasting, less invasive treatments for more common, chronic eye conditions.

What you’ll see

We’ll show you how we apply advanced gene technology to create less invasive and more effective treatments for vision loss.

Talk to us about

• How can emerging genetic technologies, such as gene editing, be used to treat eye diseases?
• Can we tailor gene therapy to achieve a safe and effective treatment to prevent vision loss?
• How can nanocarrier technology be used to improve drug and gene delivery for ocular diseases?
• Could eye drops one day reduce the need for regular anti-VGEF injections?